Cargando...
Emerging Variants of Castration-Resistant Prostate Cancer
Metastatic castration resistant prostate cancer (CRPC) is associated with substantial clinical, pathologic, and molecular heterogeneity. Most tumors remain driven by androgen receptor (AR) signaling, which has clinical implications for patient selection for AR-directed approaches. However, histologi...
Gardado en:
| Publicado en: | Curr Oncol Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479409/ https://ncbi.nlm.nih.gov/pubmed/28361223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0593-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|